Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies
Authors
Keywords
-
Journal
ChemMedChem
Volume 14, Issue 21, Pages 1863-1872
Publisher
Wiley
Online
2019-09-24
DOI
10.1002/cmdc.201900508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants
- (2018) Arun K. Ghosh et al. ChemMedChem
- Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid
- (2018) Ian W. Windsor et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants
- (2017) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency
- (2017) Manabu Aoki et al. eLife
- Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
- (2016) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir
- (2014) H. Hayashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P2′ Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Nonpeptidic HIV-1 Protease Inhibitors Containing P2bis-Tetrahydrofuran Moiety
- (2013) Ravikiran S. Yedidi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- JLigand: a graphical tool for theCCP4 template-restraint library
- (2012) Andrey A. Lebedev et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV
- (2012) Arun K. Ghosh et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis
- (2012) G. Sterrantino et al. INFECTION
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Design of HIV-1 Protease Inhibitors with C3-Substituted Hexahydrocyclopentafuranyl Urethanes as P2-Ligands: Synthesis, Biological Evaluation, and Protein–Ligand X-ray Crystal Structure
- (2011) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Effect of Highly Active Antiretroviral Therapy on the Survival of HIV-Infected Children in a Resource-Deprived Setting: A Cohort Study
- (2011) Andrew Edmonds et al. PLOS MEDICINE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters
- (2010) Chen-Hsiang Shen et al. FEBS Journal
- In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Protease Inhibitors
- (2010) Y. Koh et al. JOURNAL OF VIROLOGY
- Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: Relevance to drug resistance
- (2010) Jane M. Sayer et al. PROTEIN SCIENCE
- Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients
- (2009) Sandra De Meyer et al. AIDS
- The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
- (2009) Samuel Broder ANTIVIRAL RESEARCH
- P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines
- (2009) Hiromi Fujimoto et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naive Individuals
- (2009) S. Hue et al. JOURNAL OF VIROLOGY
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- (2008) S.-F. Zhou XENOBIOTICA
- Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance
- (2007) Arun K. Ghosh et al. ACCOUNTS OF CHEMICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now